A Comparison of Nivolumab-based Treatments in a Real-world PD-L1 Positive Metastatic Melanoma Population in the US
Clinical trial NCT03732560 · COMPLETED
Trial details
- NCT number
- NCT03732560
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2018-07-31
- Primary completion
- 2021-03-25
- Enrollment
- 600
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.